Deerfield commits $50M-plus to translational drug R&D at the Broad
Deerfield Management and the famous Broad Institute of MIT and Harvard have come up with a novel plan for pursuing translational drug research work.
In the deal announced this morning, Deerfield will invest more than $50 million into projects at the Broad over the next five years. And the biotech investor plans to follow up with support to create new biotechs out of the research, with “significant additional resources” available for development work.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.